Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s footer/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:59:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:40:23.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma as a related MeSH term and added a Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:41.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:59:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:32.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted a government funding status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:00:23.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.